Podcasts about zeltiq

Join us in celebrating this milestone of Terri's 100th episode as Terri Ross shares her journey, expertise, and future aspirations in the aesthetic industry. Don't miss out on this enlightening conversation, and look forward to more inspiring content from "In Touch with Terri." Stay tuned and connected with Terri's tribe for more transformative insights and strategies. Resources: Terri Ross Consulting Website Terri's Instagram: @terrirossconsulting Sales and Business Mastery Mentorship: Terri's Patreon.com Terri Ross is a seasoned consultant in the aesthetic medical industry with an unmatched track record in sales and business operations. She is the Founder and CEO of Terri Ross Consulting, where she devotes her expertise to helping aesthetic practices maximize their profitability and operational efficiency. Terri has a noteworthy history of achieving significant success in medical sales, serving as a Director for renowned Fortune 500 companies like Johnson & Johnson and Zeltiq. Her journey from sales executive to a managing partner at a top med spa in Beverly Hills underpins her deep industry insight and her commitment to empowering aesthetic professionals through education and mentorship. Episode Summary: In this milestone 100th episode of "In Touch with Terri," Terri Ross deep dives into a vulnerable and inspiring retelling of her incredible journey from humble beginnings to industry leader. Engaging in a heartfelt conversation with InTouch with Terri, producer and longtime friend, Tim Cicciarelli, Terri reflects on the personal and professional milestones that shaped her career in the medical aesthetics industry. Released on Valentine's Day in celebration of five years of podcasting, this episode promises insight, emotion, and empowerment, appealing to listeners who aspire to make their mark in medical aesthetics. Terri opens up about her early life in Michigan, where she balanced the challenges of a blue-collar upbringing with an unyielding drive to succeed. She shares pivotal transitions, including her transformation from a successful sales executive at top pharmaceutical companies to a managing partner of a med spa in Beverly Hills. Emphasizing resilience, Terri transitions to discussing her significant pivots during the COVID-19 pandemic, which led to the creation of innovative services through her consulting company. Highlighting her role as a single mother and how this has driven her determination, Terri credits her daughter as a key motivator in her achievements. This episode is as much a celebration of growth as it is a message of hope and possibility for anyone seeking success in the aesthetics industry. Key Takeaways: Terri Ross celebrates five years of impactful podcasting with her 100th episode, sharing personal stories and professional insights. Through sheer determination, Terri transitioned from a corporate sales career into a thriving business consultant in the medical aesthetics field. Highlighting the importance of resilience, Terri reflects on overcoming industry challenges and adapting to the pandemic by launching SaaS solutions. Terri Ross Consulting underscores the importance of training and operational efficiency, offering tailored services to optimize practice performance. Family remains central to Terri's journey, as she balances parenting with her professional endeavors, inspiring her daughter in the process. Notable Quotes: "You have to bet on yourself, and I'm going to bet on me." "I worked harder than everyone else, and I wanted a better life, and I wanted to do it on my own." "It took me six months to get that job. Tenacity, my God, you don't even know." "I never say no, because I'm scrappy, and I always seek opportunities." "My desire to democratize knowledge is the sole purpose, to provide aesthetic professionals insights and strategies."  

Join us in celebrating this milestone of Terri's 100th episode as Terri Ross shares her journey, expertise, and future aspirations in the aesthetic industry. Don't miss out on this enlightening conversation, and look forward to more inspiring content from "In Touch with Terri." Stay tuned and connected with Terri's tribe for more transformative insights and strategies. Resources: Terri Ross Consulting Website Terri's Instagram: @terrirossconsulting Sales and Business Mastery Mentorship: Terri's Patreon.com Terri Ross is a seasoned consultant in the aesthetic medical industry with an unmatched track record in sales and business operations. She is the Founder and CEO of Terri Ross Consulting, where she devotes her expertise to helping aesthetic practices maximize their profitability and operational efficiency. Terri has a noteworthy history of achieving significant success in medical sales, serving as a Director for renowned Fortune 500 companies like Johnson & Johnson and Zeltiq. Her journey from sales executive to a managing partner at a top med spa in Beverly Hills underpins her deep industry insight and her commitment to empowering aesthetic professionals through education and mentorship. Episode Summary: In this milestone 100th episode of "In Touch with Terri," Terri Ross deep dives into a vulnerable and inspiring retelling of her incredible journey from humble beginnings to industry leader. Engaging in a heartfelt conversation with InTouch with Terri, producer and longtime friend, Tim Cicciarelli, Terri reflects on the personal and professional milestones that shaped her career in the medical aesthetics industry. Released on Valentine's Day in celebration of five years of podcasting, this episode promises insight, emotion, and empowerment, appealing to listeners who aspire to make their mark in medical aesthetics. Terri opens up about her early life in Michigan, where she balanced the challenges of a blue-collar upbringing with an unyielding drive to succeed. She shares pivotal transitions, including her transformation from a successful sales executive at top pharmaceutical companies to a managing partner of a med spa in Beverly Hills. Emphasizing resilience, Terri transitions to discussing her significant pivots during the COVID-19 pandemic, which led to the creation of innovative services through her consulting company. Highlighting her role as a single mother and how this has driven her determination, Terri credits her daughter as a key motivator in her achievements. This episode is as much a celebration of growth as it is a message of hope and possibility for anyone seeking success in the aesthetics industry. Key Takeaways: Terri Ross celebrates five years of impactful podcasting with her 100th episode, sharing personal stories and professional insights. Through sheer determination, Terri transitioned from a corporate sales career into a thriving business consultant in the medical aesthetics field. Highlighting the importance of resilience, Terri reflects on overcoming industry challenges and adapting to the pandemic by launching SaaS solutions. Terri Ross Consulting underscores the importance of training and operational efficiency, offering tailored services to optimize practice performance. Family remains central to Terri's journey, as she balances parenting with her professional endeavors, inspiring her daughter in the process. Notable Quotes: "You have to bet on yourself, and I'm going to bet on me." "I worked harder than everyone else, and I wanted a better life, and I wanted to do it on my own." "It took me six months to get that job. Tenacity, my God, you don't even know." "I never say no, because I'm scrappy, and I always seek opportunities." "My desire to democratize knowledge is the sole purpose, to provide aesthetic professionals insights and strategies."  

This week, we welcome back Keith Grossman. Keith has been a leader in the medical technology industry for more than 35 years. He is currently the Chairman of the Board of Nevro Corporation (NVRO), where he was previously President and CEO from 2019 through April 2023. Prior to Nevro, he was named President and CEO of Thoratec Corp. (THOR) for the second time in 2014. He led the company's return to growth, a 2.5x increase in company value, and its $3.4 billion acquisition by St. Jude Medical in 2015. He previously served as the CEO, President, and Director of Conceptus, Inc. (CPTS) from 2011 to 2013, where he took the company from negative sales growth to over 20% growth, tripled EBIDTA, and led the company's sale to Bayer Healthcare for over $1.1 billion, a 3x increase in the company's value before his arrival. Prior to Conceptus, Keith served as managing director of TPG (Texas Pacific Group), a private equity firm, as a member of its healthcare investment team. Prior to TPG, Mr. Grossman served as Thoratec's President, Chief Executive Officer, and director for the first ten years of its growth as a commercial company. Prior to Thoratec, he held a number of commercial and general management roles with companies, including SulzerMedica and American Hospital Supply Corp. He currently also serves as Vice Chairman of Alcon, Inc., and is on the board of Outset Medical, Inc. and previously served as a member of the Board of directors of Intuitive Surgical, Inc., Kyphon, Inc., ViewRay, Inc., Zeltiq, Inc, and a number of privately held medical device companies. Keith received a B.S. in life sciences from The Ohio State University and an M.B.A. from Pepperdine University.

Imagine a resume that runs from Solta, Medicis, and Cutera to Zeltiq, Allergan, and Soliton — success building on success in a masterclass on how to take an aesthetic enterprise from a promising player to a dominant force in the industry.As a leader with no less than seven M&A events to his name, Brad Hauser reflects on his titanic track record in this illuminating interview with Dr. Grant Stevens. As Brad details the swath he has cut across the land of medical aesthetics, it only serves to make one want to keep a watchful eye on Brad's latest ventures as a board member for Candesant Biomedical and the Chief Product Officer of BeautyHealth — a position he assumed soon after this episode was recorded.Tune in to find out how he did it, along with a peek at what's in store for the future on the latest episode of The Technology of Beauty.

This week we interview Keith Grossman. Keith was named CEO and President of Nevro in March of 2019. Keith has over 30 years of experience in the medical device field. He served most recently, and for the second time, as the President, Chief Executive Officer, and director of Thoratec Corporation, leading up to its 2015 sale to St. Jude Medical. He currently serves as Vice Chairman of Alcon, Inc., and Chairman of Outset Medical, Inc. and previously served as a member of the Board of directors of Intuitive Surgical, Inc., Kyphon, Inc., ViewRay, Inc., Zeltiq, Inc, and a number of privately held medical device companies.

To start off with a bang for the first episode of 2022, Dr. Grant Stevens invites InBrace Senior VP Brent Hauser to discuss a category creator that could rival Fraxel, CoolSculpting, and Botox … but in the field of aesthetic dentistry. With Solta, Zeltiq, Allergan, and AbbVie on his resume, Brent brings over two decades of aesthetic experience to his latest venture — a truly revolutionary Smartwire technology for straightening teeth that comes straight out of the aerospace industry. Brent describes in detail how InBrace uses patient-specific and data-driven solutions to create an experience that promises to be faster, more convenient, and more comfortable than existing treatments. Tune in now for a fascinating look at how this technology can remake aesthetic dentistry.

Today is a very exciting day! We will be discussing a new longer-lasting neuromodulator. In other words a longer-lasting "Botox". We will be sitting down with Mark Foley the President and CEO of Revance, the company that is bringing this new product to the market. Listen in as we share the latest and greatest info! More info on Mark... Mark Foley is currently the President and CEO of Revance Therapeutics and has served as a member of the Company's board of directors since September 2017. Previously, Mr. Foley was Chairman, President and CEO of ZELTIQ Aesthetics (ZLTQ). During his tenure, he led ZELTIQ's growth from $68 million in annual revenue in 2012 to over $350 million in 2016, resulting in an appreciation of the Company's stock of greater than tenfold and acquisition by Allergan (AGN) in April of 2017 for $2.5B. Mr. Foley also served as a Managing Director of RWI Ventures, a venture capital firm focused on life sciences, networking, semiconductor and software investments, from 2004 to 2018. Mr. Foley has over 25 years of experience in the health care field, having served in a variety of senior operating roles in both large public companies and venture-backed startups, including U.S. Surgical Corporation, Guidant Corporation, Devices for Vascular Intervention (acquired by Eli Lilly), Perclose (acquired by Abbott) and Ventrica (acquired by Medtronic), where he was the founder and CEO. Also, he has partnered with a number of entrepreneurs to assist with the formation and capitalization of new health care companies while also serving as a Senior Advisor, Executive Chairman, interim CEO and board member to a number of medical device companies. Mr. Foley currently serves on the board of directors of Glaukos (GKOS), Si-Bone (SIBN) and as chairman of the board for ULab and HintMD. He also co-chairs the Aesthetics Innovation Summit and was chairman of Arrinex up and until its acquisition by Stryker in the spring of 2019. Mr. Foley received his BA from the University of Notre Dame in 1987 and is a named inventor on 17 patent applications. --- Send in a voice message: https://anchor.fm/janet-allenby/message

Join us on BLGFG today to learn more about CoolSculpting from the Vice President of the company! Today we will explore the topic of BodySculpting with CoolSculpting and CoolTone and what is coming next in this exciting field of non-surgical body treatments. More about Brad... Brad Hauser has been Vice President, R&D and General Manager for CoolSculpting at Allergan since ZELTIQ was acquired in April 2017. He joined the CoolSculpting team in 2013, as Vice President of Product and Clinical Strategy, and later became Senior Vice President of Research and Development. Previous to ZELTIQ, he has held multiple roles in the aesthetic industry and helped develop products like Fraxel, Thermage, Clear and Brilliant, Excel V (for vascular lesions) and Enlighten (for tattoo removal). Mr. Hauser received his Bachelor of Arts in Human Biology from Stanford University. --- Send in a voice message: https://anchor.fm/janet-allenby/message

Allergan is always exploring exciting new technologies. Primarily, they look for non-invasive techniques that allow patients to come in and go back to their normal lifestyle nearly immediately.CoolTone is one of their products, and it’s an electromagnetic device that is cleared for strengthening, toning, and firming of the muscles of the abdomen, buttocks, and thighs. This device does not replace going to the gym, but it can definitely be an addition to your workout.On today’s episode, Brad and I have an interesting talk about the new device that he and his team have worked on, called, “CoolTone”. He explains to us what it is, how it works, and the benefits of using it.Brad Hauser has been Vice President, R&D and General Manager for CoolSculpting at Allergan since ZELTIQ was acquired in April 2017. He joined the CoolSculpting team in 2013, as Vice President of Product and Clinical Strategy, and later became Senior Vice President of Research and Development. Previous to ZELTIQ, he has held multiple roles in the aesthetic industry, including Executive Vice President of Commercial Operations for Cutera, Director of Research and Development at Medicis and Managing Director of Product and Clinical Marketing at Solta Medical. Mr. Hauser received his Bachelor of Arts in Human Biology from Stanford University.So, listen to Episode 04 of Beauty Heroes, to learn about a brand new body contouring device that has just been launched on the market.Questions I ask:You've been in the non-invasive body contouring space for many years. Can you tell me how you got started in this field and what your background is? (01:43)Does it do anything to the skin and the fat layer? (04:28)You mentioned this is good for the abdomen, buttocks, and thighs. What about other body parts? Is CoolTone looking at any other applications? (04:59)Does it hurt or is it just something that you haven't experienced before? (06:36)Do you find a difference between exercisers and non-exercisers with CoolTone results? (09:43)What is next for the Allergan Body Contouring division?In this episode, you will learn:About CoolTone – what it is and how it works. (03:20)The results of the studies done on CoolTone. (07:08)The functional benefits of CoolTone, besides the aesthetics effects. (08:12)What the maintenance protocol consists of. (10:51)Why CoolTone is different than other similar devices available on the market. (12:26)Connect with Dr. BonakdarConnect with Brad:LinkedInAllergan Website See acast.com/privacy for privacy and opt-out information.

Aubrey Rankin, CEO and President of HintMD shares how the young start-up’s path of discovery has created a dynamic platform that solves a key problem for doctors. Aubrey gives insight into their pivot to help undertreated patients in the market. Aubrey also reveals their latest data results, industry trends towards subscriptions and how their technology manages the complexities in membership programs in aesthetics.Rankin also gives us details about his unique background - from growing up in South Africa, to a key role at Zeltiq leading Asia Pacific commercial sales and eventually, to his current role as CEO. Rankin is a featured speaker at our upcoming Aesthetics Innovation Summit on May 15th in New Orleans. Attend AIS – a one-day gathering of the professionals driving the most dynamic sector in healthcare.

Welcome to the Aesthetics Innovators Podcast. In this episode, host Grant Stevens, MD, the founder and medical director of Marina Plastic Surgery and The Orange Twist Institute, discusses the future of aesthetics innovation with Mark Foley, the former CEO of Zeltiq. Dr. Stevens, Foley, and Josh Makower, MD, general partner at NEA, serve as co-chairs of the Aesthetics Innovation Summit, which will take place on May 15 in New Orleans prior to the ASAP’s annual meeting.

As the CEO of medical technology company ZELTIQ, Mark Foley was on the front lines of a major business transformation. Venrock’s Bryan Roberts talks to Foley about turning the company around by changing the business model and swapping out the majority of leadership, culminating in the successful acquisition by Allergan for $2.4 billion in April 2017. But the exit wasn’t all smooth sailing. Foley shares details on the initial failed bids that rocked the company’s culture, how he managed morale during this tricky time, and what led to the successful deal in the end. He also shares how investors can recover after an initial stumble, and how he made the transition from VC to CEO successfully.  

Freelance Business Journalist and Editor of Betaville Website Ben Harrington says the fall out of Kraft-Unilever deal has been unprecedented and goes to list the names thrown around on the street as the potential targets for Kraft. The list includes names like Colgate, Reckitt Benckiser, and Coco-Cola. Other key M&A deals discussed in this segment are - · Allergan to buy Zeltiq for $2.48 Billion · Hologic to buy Cynosure to expand into medical aesthetics for $1.65 billion #Betaville, #M&A, #KraftHeinz, #Unilever, #Colgate, #Reckitt #Benckiser, #Coco-Cola, #Allergan, #Zeltiq, #Hologic, #Cynosure, #stocks, #equities, #UK, #US, #deals

Besides having a unique technology, cyrolipolysis, Zeltiq may be able to effectively use this revolutionary platform to address needs beyond the original intention to selectively reduce fat in a non-surgical way.  In 2017, it plans to use CoolSculpting to treat grade 2 cellulite and acne.  Grade 2 cellulite affects a large portion of women, while some other devices target grades 3 or higher, which are characterized by unsightly manifestations like cottage cheese thighs.  By 2018, management hopes to introduce CoolSculpting to treat acne.  In this stock research podcast, we discuss the research of Dr. Rox Anderson of the Harvard Medical School, who delves into the history of acne treatments.  Powdered dry ice and acetone pastes were prevalent in the 1940s and 1950s, but were pushed aside by antibiotics and retinoids.  A tightly controlled approach to cyrolipolysis may improve outcomes and address worries of antibiotic resistance and fetal retinoid syndrome.  Using one platform to treat three conditions would present a unique competitive advantage to Zeltiq, should it succeed.

Zeltiq has single handedly created a new market for reducing fat that targets the moderately overweight segment.  It has become the fastest growing aesthetic treatment, which was already notable for the tremendous demand for neuromodulators like Botox and hyaluronic acid fillers like Restylane and Juvaderm.  In Part 1 of this podcast, we explore how Zeltiq's high margin consumables and systems have permitted the company to break through the barriers that often restrain new aesthetic products.  We also discuss why cyrolipolysis, an affordable and non-surgical procedure, is popular with a new group of women and also men who are approaching practitioners for help in sculpting difficult areas of their bodies that they can't control with dieting or exercise alone.

Video Highlights 0:13 Freezing the fat ads 0:29 CoolSculpting by Zeltiq 0:32 Non-invasive fat treatment 0:50 Fat reduction through freezing 0:56 Decrease rate of 20-25% 1:04 Choosing the right areas to target 1:09 Three common areas where you can use CoolSculpting 1:58 Want this service? Call 808-501-3223 Hi, this is Dr Michael Persky from Encino […] The post Freezing the Fat in Los Angeles with CoolSculpting by Zeltiq appeared first on Dr. Persky.

One of NYC's top plastic surgeons, Dr. Carlin Vickery, talks about the new technologies being used for plastic surgery. The FDA has recently approved the cohesive gel, known as gummy bear implants, which is crucial to breast reconstruction patients. Another new technology that has recently come out is CoolSculpting by Zeltiq. CoolSculpting by Zeltiq is a cutting-edge process that utilizes a cooling system to target and destroy fat cells in selected areas of the body. Dr. Vickery is one of New York City's leading plastic surgeons. For more information, visit our website at www.5thavesurgery.com

Ultrashape and Zeltiq - 2 noninvasive methods to remove fat